143049
Aldrithiol™-2
98%
Sinónimos:
2,2′-Dithiodipyridine, 2,2′-Dipyridyl disulfide
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula empírica (notación de Hill):
C10H8N2S2
Número CAS:
Peso molecular:
220.31
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
218-343-1
Beilstein/REAXYS Number:
154629
MDL number:
Assay:
98%
Form:
solid
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleQuality Level
assay
98%
form
solid
mp
56-58 °C (lit.)
solubility
methanol: soluble 50 mg/mL, clear to very slightly hazy, colorless to faintly brownish-yellow
functional group
disulfide
storage temp.
2-8°C
SMILES string
S(Sc1ccccn1)c2ccccn2
InChI
1S/C10H8N2S2/c1-3-7-11-9(5-1)13-14-10-6-2-4-8-12-10/h1-8H
InChI key
HAXFWIACAGNFHA-UHFFFAOYSA-N
General description
Aldrithiol™-2 is a nucleocapsid zinc finger targeting compound and can abrogate the infectivity of human immunodeficiency virus type-1 virions. It is a thiol reagent.
Application
Thiol reagent. Employed with PPh3 as a condensing agent in the amidation of carboxylic acid enantiomers for HPLC separation.
Aldrithiol™-2 was used in the synthesis of adenosine-5′-phosphoimidazolide. It was employed with PPh3 as a condensing agent in the amidation of carboxylic acid enantiomers for HPLC separation.
Legal Information
Aldrithiol is a trademark of Sigma-Aldrich Co. LLC
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Clase de almacenamiento
11 - Combustible Solids
wgk
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Gloves
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Journal of Chromatography A, 662, 87-87 (1994)
J L Rossio et al.
Journal of virology, 72(10), 7992-8001 (1998-09-12)
Whole inactivated viral particles have been successfully used as vaccines for some viruses, but procedures historically used for inactivation can denature virion proteins. Results have been inconsistent, with enhancement of disease rather than protection seen in some notable instances following
Analytical Sciences, 10, 17-17 (1994)